Dynavax Technologies
DVAX
#4890
Rank
ยฃ1.33 B
Marketcap
ยฃ11.38
Share price
38.19%
Change (1 day)
9.52%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: ยฃ1.33 Billion

As of December 2025 Dynavax Technologies has a market cap of ยฃ1.33 Billion. This makes Dynavax Technologies the world's 4890th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ1.33 B-1.84%
2024ยฃ1.36 B-3.99%
2023ยฃ1.41 B26.41%
2022ยฃ1.12 B-10.26%
2021ยฃ1.25 B247.56%
2020ยฃ0.35 B-1.67%
2019ยฃ0.36 B-19.26%
2018ยฃ0.45 B-45.95%
2017ยฃ0.83 B579.8%
2016ยฃ0.12 B-80.32%
2015ยฃ0.62 B120.02%
2014ยฃ0.28 B-8.77%
2013ยฃ0.31 B-3.12%
2012ยฃ0.32 B18.99%
2011ยฃ0.27 B13.02%
2010ยฃ0.23 B403.15%
2009ยฃ47.63 M108.52%
2008ยฃ22.84 M-77.67%
2007ยฃ0.10 B-45.05%
2006ยฃ0.18 B222.05%
2005ยฃ57.79 M-41.41%
2004ยฃ98.65 M

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Dynavax Technologies was reported to be:

ยฃ0.96 Billion
by Nasdaq info icon info icon
ยฃ1.33 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
ยฃ84.32 M-93.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ19.14 B 1,332.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ196.79 B 14,622.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ115.41 B 8,534.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ212.15 B 15,771.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ73.33 B 5,386.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ105.33 B 7,780.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ26.95 B 1,916.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ133.10 B 9,857.44%๐Ÿ‡บ๐Ÿ‡ธ USA